Table 2.
Results of biochemical and imaging examination in OBI patients at week 0.
| Items | Group A (n=44) | Group B (n=39) |
|---|---|---|
| Biochemical | ||
| Alb, M (Q1,Q3), g/L | 49.00 (47.00,50.00) | 48.00 (45.00,50.00) |
| ALT, M (Q1,Q3), U/L | 20.50 (13.00,28.00) | 22.00 (15.00,33.00) |
| GGT, M (Q1,Q3), U/L | 20.50 (15.00,33.00) | 24.00 (16.00,41.00) |
| TBIL, M (Q1,Q3), μmol/L | 12.05 (8.15,16.68) | 11.00 (7.10,14.00) |
| HBV related liver dysfunction n° (%) | 2 (4.55) | 3 (7.70) |
| Imaging | ||
| Hepatic fibrosis n° (%) | 27(61.36) | 25(64.10) |
M, median; Q1, first quartile; Q3, third quartile; n°, number of cases.